Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

First clinical study of ONS-3010 meets primary endpoints

Feb. 13, 2015

Novo Nordkisk reports development of anti-uPA MAbs

Feb. 13, 2015

Anika Therapeutics files for U.S. and E.U. approval of Cingal for osteoarthritis of the knee

Feb. 12, 2015

FDA expands clearance for Nanotherapeutics bone filler to use in spinal fusion surgery

Feb. 11, 2015

Cadila Pharmaceuticals divulges agents for inflammation

Feb. 10, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

Proteostasis Therapeutics selects PTI-130 as a development candidate for CF

Feb. 6, 2015

Amgen releases topline results from phase III study of adalimumab biosimilar ABP-501

Feb. 5, 2015

NIHR and Janssen to study rheumatoid arthritis response to anti-TNF therapy

Feb. 5, 2015

Flexion Therapeutics initiates phase III trial of FX-006 for pain in osteoarthritis of the knee

Feb. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...